1. Home
  2. PRAX vs VNOM Comparison

PRAX vs VNOM Comparison

Compare PRAX & VNOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$327.25

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

VNOM

Viper Energy Inc.

N/A

Current Price

$39.94

Market Cap

8.2B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
PRAX
VNOM
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
8.2B
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
PRAX
VNOM
Price
$327.25
$39.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
20
Target Price
★ $650.00
$55.63
AVG Volume (30 Days)
420.7K
★ 2.2M
Earning Date
11-09-2026
11-02-2026
Dividend Yield
N/A
★ 6.16%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.99
Revenue
N/A
★ $1,395,000,000.00
Revenue This Year
N/A
$91.68
Revenue Next Year
$41,442.59
N/A
P/E Ratio
★ N/A
$20.47
Revenue Growth
N/A
★ 62.02
52 Week Low
$160.11
$35.10
52 Week High
$392.70
$51.13

Technical Indicators

Market Signals
Indicator
PRAX
VNOM
Relative Strength Index (RSI) 63.91 34.21
Support Level $307.93 N/A
Resistance Level $347.63 $48.29
Average True Range (ATR) 16.67 1.34
MACD 5.68 -0.84
Stochastic Oscillator 96.95 1.71

Price Performance

Historical Comparison
PRAX
VNOM

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About VNOM Viper Energy Inc.

Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.

Share on Social Networks: